CD62L
| Aliases: | CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL, LYAM1, PLNHR, TQ1 |
|---|---|
| Other: | L-selectin|CD62 antigen-like family member L|gp90-MEL|leukocyte surface antigen Leu-8|leukocyte-endothelial cell adhesion molecule 1|lymph node homing receptor|lymphocyte adhesion molecule 1|pln homing receptor |
This gene encodes a cell surface adhesion molecule that belongs to a family of adhesion/homing receptors. The encoded protein contains a C-type lectin-like domain, a calcium-binding epidermal growth factor-like domain, and two short complement-like repeats. The gene product is required for binding and subsequent rolling of leucocytes on endothelial cells, facilitating their migration into secon... see more
Vio Bright 515
| Common Laser: | 488 |
|---|---|
| Common Filter: | 525/50 |
| Excitation Peak: | 488 |
| Emission Peak: | 514 |
Vio®Bright® B515 from Miltenyi has an excitation peak at 488 nm and an emission peak at 514. It is comparable to BB515 in flow cytometry.
Popular CD62L Vio Bright 515 Antibodies
| Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
|---|---|---|---|---|---|---|
|
Miltenyi Biotec 130-129-459 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC | CD62L Human |
Mouse IgG1,κappa 145/15 |
30 tests in 60 µL $210 |
Details | |
|
Miltenyi Biotec 130-129-318 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC | CD62L Human |
Mouse IgG1,κappa 145/15 |
100 tests in 200 µL $500 |
Details | |
|
Miltenyi Biotec 130-130-589 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC,Mass Cytometry | CD62L Human |
Human IgG1 REA615 |
30 tests in 60 µL $210 |
Details | |
|
Miltenyi Biotec 130-129-319 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC,Mass Cytometry | CD62L Mouse |
Rat IgG2a κ MEL14-H2.100 |
30 µg in 200 µL $200 |
Details | |
|
Miltenyi Biotec 130-130-551 |
FC,MICS (MACSima Imaging Cyclic Staining),IF,IHC,Mass Cytometry | CD62L Human |
Human IgG1 REA615 |
100 tests in 200 µL $510 |
Details | |
| Browse CD62L / Vio Bright 515 antibodies. | ||||||

